- Home
- JG vs BRNS Comparison
JG vs BRNS Comparison
Compare JG & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JG
- BRNS
- Stock Information
- Founded
- JG 2012
- BRNS 2016
- Country
- JG China
- BRNS United Kingdom
- Employees
- JG N/A
- BRNS N/A
- Industry
- JG Computer Software: Programming Data Processing
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- JG Technology
- BRNS Health Care
- Exchange
- JG Nasdaq
- BRNS Nasdaq
- Market Cap
- JG 58.2M
- BRNS 48.3M
- IPO Year
- JG 2018
- BRNS 2021
- Fundamental
- Price
- JG $9.65
- BRNS $1.06
- Analyst Decision
- JG
- BRNS Strong Buy
- Analyst Count
- JG 0
- BRNS 1
- Target Price
- JG N/A
- BRNS $3.00
- AVG Volume (30 Days)
- JG 7.5K
- BRNS 37.9K
- Earning Date
- JG 11-13-2025
- BRNS 11-05-2025
- Dividend Yield
- JG N/A
- BRNS N/A
- EPS Growth
- JG N/A
- BRNS N/A
- EPS
- JG N/A
- BRNS N/A
- Revenue
- JG $48,999,972.00
- BRNS $14,969,000.00
- Revenue This Year
- JG $10.90
- BRNS N/A
- Revenue Next Year
- JG N/A
- BRNS N/A
- P/E Ratio
- JG N/A
- BRNS N/A
- Revenue Growth
- JG 18.82
- BRNS 1766.46
- 52 Week Low
- JG $4.24
- BRNS $0.64
- 52 Week High
- JG $20.94
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- JG 45.31
- BRNS 40.62
- Support Level
- JG $9.57
- BRNS $1.08
- Resistance Level
- JG $10.20
- BRNS $1.20
- Average True Range (ATR)
- JG 0.36
- BRNS 0.09
- MACD
- JG 0.02
- BRNS -0.01
- Stochastic Oscillator
- JG 9.55
- BRNS 3.33
About JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.